MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,120 | -18.9% | 10,612 | +0.8% | 0.00% | -50.0% |
| Q2 2023 | $130,813 | -39.9% | 10,524 | -32.2% | 0.00% | -33.3% |
| Q1 2023 | $217,617 | +5.1% | 15,533 | +7.4% | 0.00% | 0.0% |
| Q4 2022 | $206,966 | -37.8% | 14,463 | +11.0% | 0.00% | -50.0% |
| Q3 2022 | $333,000 | -8.8% | 13,028 | +1.5% | 0.01% | -14.3% |
| Q2 2022 | $365,000 | -15.1% | 12,838 | +5.3% | 0.01% | 0.0% |
| Q1 2022 | $430,000 | -19.5% | 12,197 | -4.2% | 0.01% | -12.5% |
| Q4 2021 | $534,000 | -5.7% | 12,737 | +10.5% | 0.01% | -27.3% |
| Q3 2021 | $566,000 | +57.7% | 11,530 | +33.9% | 0.01% | +57.1% |
| Q2 2021 | $359,000 | – | 8,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |